Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cnacer cells more sensitive to
light to kill tumor cells. Brachytherapy uses radiation to damage tumor cells. Photodynamic
therapy combined with brachytherapy may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy plus brachytherapy
in treating patients with recurrent lung cancer that is blocking the lung passages.